Will gastric adenocarcinoma increase or decrease the white blood cell count?

Gastric Adenocarcinoma Typically Increases WBC Count

Gastric adenocarcinoma is associated with elevated white blood cell counts, particularly in patients with H. pylori infection and higher tumor burden, though the cancer itself does not directly cause leukocytosis in most cases.

Initial Assessment Context

When evaluating WBC count in gastric adenocarcinoma patients, guidelines recommend obtaining a full blood count as part of initial staging 1. This baseline assessment serves multiple purposes: detecting iron deficiency anemia (common in gastric cancer) and establishing baseline hematologic parameters before treatment 1.

The WBC-Gastric Cancer Relationship

Preoperative Elevation

• Higher baseline WBC counts are associated with worse prognosis in gastric cancer patients 2, 3
• Preoperative leukocytosis (elevated WBC) is an independent negative prognostic factor for survival (HR=1.602, p=0.002) 2
• Population studies demonstrate that higher WBC levels increase gastric cancer risk, with the highest quartile (≥6.4 × 10³ cells/μL) showing 2.22-fold increased risk compared to the lowest quartile 4

The H. Pylori Connection

The elevation in WBC count is often mediated through chronic H. pylori infection rather than the cancer itself:

• H. pylori-positive patients show significantly higher WBC counts than H. pylori-negative patients 5
• The relationship between H. pylori infection burden (measured by DPM values) and WBC count follows a non-linear pattern with threshold effects at DPM values of 40 and 155 5
• H. pylori-seropositive subjects with higher WBC counts demonstrate significantly greater gastric cancer risk 4

Postoperative Changes

A critical caveat: WBC count typically decreases after gastric cancer surgery 2, 6:

• Mean WBC significantly drops post-gastrectomy, with 17.4% of patients developing postoperative leukopenia (defined as preoperative WBC ≥4.0 × 10⁹/L dropping to <4.0 × 10⁹/L postoperatively) 2
• Neutrophil counts decrease more significantly than lymphocyte counts 2
• Postoperative leukopenia combined with preoperative leukocytosis indicates the worst prognosis (median survival 27.5 vs 57.3 months, p<0.001) 2

Clinical Implications

Prognostic Stratification

The perioperative inflammatory status matters significantly:

• Pre-chemotherapy leukocyte count <4.0 × 10⁹/L predicts worse disease-free survival (p=0.028) and overall survival (p=0.016) 3
• Maximum postoperative WBC count (WBCmax) is an independent prognostic factor (HR=1.746, p=0.040) 6
• Combined perioperative inflammation scores using pre-CRP and WBCmax provide superior prognostic stratification 6

Diagnostic Utility

While not diagnostic alone, CBC parameters have value:

• Platelet count shows the highest AUC (0.727) for distinguishing gastric cancer from intestinal metaplasia, with 56.9% sensitivity and 79.4% specificity at cutoff 151.8 × 10⁹/L 7
• RDW, NLR, PLR, and MLR all show significant differences between gastric cancer and intestinal metaplasia 7

Common Pitfalls

1. Do not assume leukocytosis means active infection - elevated WBC in gastric cancer often reflects chronic inflammatory state from H. pylori rather than acute infection
2. Postoperative leukopenia is common and prognostically significant - monitor closely as it independently predicts poor outcomes 2, 3
3. Female patients are more likely to develop postoperative leukopenia (p=0.016) 3